{"id":"https://openalex.org/W7202397558","doi":"https://doi.org/10.1016/j.celbio.2026.100558","title":"Biomaterial-enabled in vivo T cell engineering: A new paradigm for cell therapy","display_name":"Biomaterial-enabled in vivo T cell engineering: A new paradigm for cell therapy","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7202397558","doi":"https://doi.org/10.1016/j.celbio.2026.100558","pmid":"https://pubmed.ncbi.nlm.nih.gov/42872159","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13660788"},"language":"en","primary_location":{"id":"doi:10.1016/j.celbio.2026.100558","doi":"https://doi.org/10.1016/j.celbio.2026.100558","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.celbio.2026.100558","pdf_url":null,"source":{"id":"https://openalex.org/S5407047401","display_name":"Cell Biomaterials","issn_l":"3050-5623","issn":["3050-5623"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Biomaterials","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.celbio.2026.100558","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008811525","display_name":"Sharda Pandit","orcid":"https://orcid.org/0000-0002-1392-9148","observed_orcids":["https://orcid.org/0000-0002-1392-9148"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharda Pandit","raw_affiliation_strings":["Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147062866","display_name":"S. Abbey Oliver","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Abbey Oliver","raw_affiliation_strings":["Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072437499","display_name":"Emily Joe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Joe","raw_affiliation_strings":["Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058260183","display_name":"Yevgeny Brudno","orcid":"https://orcid.org/0000-0003-2963-3293","observed_orcids":["https://orcid.org/0000-0003-2963-3293"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I137902535","display_name":"North Carolina State University","ror":"https://ror.org/04tj63d06","country_code":"US","type":"education","lineage":["https://openalex.org/I137902535"]},{"id":"https://openalex.org/I4210131205","display_name":"Lampe Joint Department of Biomedical Engineering","ror":"https://ror.org/03hakdk41","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177","https://openalex.org/I137902535","https://openalex.org/I4210131205"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yevgeny Brudno","raw_affiliation_strings":["Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. Chapel Hill, NC, USA","Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC, USA","Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":"https://orcid.org/0000-0003-2963-3293","affiliations":[{"raw_affiliation_string":"Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I137902535","https://openalex.org/I4210131205"]},{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5058260183"],"corresponding_institution_ids":["https://openalex.org/I114027177","https://openalex.org/I137902535","https://openalex.org/I4210131205","https://openalex.org/I4390039329"],"apc_list":{"value":9350,"currency":"USD","value_usd":9350},"apc_paid":{"value":9350,"currency":"USD","value_usd":9350},"fwci":2.5933,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.92612564,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":95},"biblio":{"volume":null,"issue":null,"first_page":"100558","last_page":"100558"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.6425999999046326,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.6425999999046326,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.23720000684261322,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.017400000244379044,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biomaterials","display_name":"biomaterials","score":0.6890000104904175},{"id":"https://openalex.org/keywords/t-cell-immunotherapy","display_name":"T cell therapy","score":0.8450000286102295},{"id":"https://openalex.org/keywords/gene-delivery","display_name":"gene delivery","score":0.7850000262260437},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7020000219345093},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.9570000171661377},{"id":"https://openalex.org/keywords/immunoengineering","display_name":"immunoengineering","score":0.5649999976158142},{"id":"https://openalex.org/keywords/genome-editing","display_name":"genome editing","score":0.4740000069141388}],"concepts":[{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5681999921798706},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4794999957084656},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41200000047683716},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39410001039505005},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3847000002861023},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3659999966621399},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.36250001192092896},{"id":"https://openalex.org/C10882517","wikidata":"https://www.wikidata.org/wiki/Q15268054","display_name":"Cell therapy","level":3,"score":0.3546000123023987},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.35280001163482666},{"id":"https://openalex.org/C2992881475","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T lymphocyte","level":3,"score":0.31459999084472656},{"id":"https://openalex.org/C2911194787","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"CAR T-cell therapy","level":5,"score":0.3018999993801117},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2962999939918518},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.27459999918937683},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.2734000086784363},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2662999927997589},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.2574000060558319},{"id":"https://openalex.org/C2908856526","wikidata":"https://www.wikidata.org/wiki/Q16252627","display_name":"Antibody therapy","level":4,"score":0.2540999948978424},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25200000405311584}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1016/j.celbio.2026.100558","doi":"https://doi.org/10.1016/j.celbio.2026.100558","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.celbio.2026.100558","pdf_url":null,"source":{"id":"https://openalex.org/S5407047401","display_name":"Cell Biomaterials","issn_l":"3050-5623","issn":["3050-5623"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Biomaterials","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13660788","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13660788/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13660788/pdf/nihms-2204009.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Biomater","raw_type":"Text"},{"id":"pmid:42872159","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42872159","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell biomaterials","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.celbio.2026.100558","doi":"https://doi.org/10.1016/j.celbio.2026.100558","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.celbio.2026.100558","pdf_url":null,"source":{"id":"https://openalex.org/S5407047401","display_name":"Cell Biomaterials","issn_l":"3050-5623","issn":["3050-5623"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Biomaterials","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4318987809","display_name":"Biomaterial Scaffolds for In Vivo CAR T Cell Manufacture","funder_award_id":"R21CA277018","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5270912174","display_name":"Image-guided, ultrasound-enhanced long-term intracranial drug delivery","funder_award_id":"R21CA246414","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000294680","display_name":null,"funder_award_id":"P01CA298971","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000863614","display_name":"Biomaterial Scaffolds for Ex Vivo and In Situ CAR-T Cell Production","funder_award_id":"R37CA260223","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000909543","display_name":"Bioinstructive Scaffolds for Potent and Affordable CAR-T Cell Therapy Against Brain Tumors","funder_award_id":"R01CA278961","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306076","display_name":"National Science Foundation","ror":"https://ror.org/021nxhr62"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7202397558.pdf","grobid_xml":"https://content.openalex.org/works/W7202397558.grobid-xml"},"referenced_works_count":54,"referenced_works":["https://openalex.org/W2042301629","https://openalex.org/W2078057254","https://openalex.org/W2260141621","https://openalex.org/W2600400434","https://openalex.org/W2607356458","https://openalex.org/W2609729296","https://openalex.org/W2799389252","https://openalex.org/W2864786814","https://openalex.org/W2889863283","https://openalex.org/W2933229048","https://openalex.org/W3034085326","https://openalex.org/W3048620969","https://openalex.org/W3102422330","https://openalex.org/W3107786127","https://openalex.org/W3155779187","https://openalex.org/W3166016270","https://openalex.org/W3173254299","https://openalex.org/W4206716689","https://openalex.org/W4220802200","https://openalex.org/W4223521732","https://openalex.org/W4226203376","https://openalex.org/W4293103728","https://openalex.org/W4295073795","https://openalex.org/W4296714474","https://openalex.org/W4307296492","https://openalex.org/W4308101956","https://openalex.org/W4310021006","https://openalex.org/W4312114776","https://openalex.org/W4312195060","https://openalex.org/W4324139688","https://openalex.org/W4389209737","https://openalex.org/W4389549468","https://openalex.org/W4390860180","https://openalex.org/W4394807197","https://openalex.org/W4395958389","https://openalex.org/W4396520630","https://openalex.org/W4399292909","https://openalex.org/W4405038972","https://openalex.org/W4405530021","https://openalex.org/W4408158807","https://openalex.org/W4408342895","https://openalex.org/W4409483368","https://openalex.org/W4409632848","https://openalex.org/W4411377019","https://openalex.org/W4411505807","https://openalex.org/W4412378589","https://openalex.org/W4414274521","https://openalex.org/W4415208806","https://openalex.org/W4417001830","https://openalex.org/W4417001837","https://openalex.org/W4417021918","https://openalex.org/W7124502634","https://openalex.org/W7128777948","https://openalex.org/W7140301762"],"related_works":["https://openalex.org/W7133497896","https://openalex.org/W4213346789","https://openalex.org/W3155091350","https://openalex.org/W4384822187","https://openalex.org/W4282916021","https://openalex.org/W4366596279","https://openalex.org/W7131670729","https://openalex.org/W4412686757","https://openalex.org/W4367679047","https://openalex.org/W4397290449"],"abstract_inverted_index":{"T":[0,126],"cell":[1,21,25,63,89,113,127],"therapies":[2,128],"have":[3,53],"transformed":[4],"treatment":[5,38],"for":[6,110],"previously":[7],"intractable":[8],"diseases.":[9],"However,":[10],"their":[11,146],"full":[12],"potential":[13],"remains":[14],"constrained":[15],"by":[16,74],"reliance":[17],"on":[18],"ex":[19],"vivo":[20,61],"manipulations,":[22],"which":[23],"reduces":[24],"quality,":[26],"drives":[27],"up":[28],"manufacturing":[29,79],"costs,":[30,77],"and":[31,40,50,81,91,103,115,149],"requires":[32],"lengthy":[33],"production":[34],"times,":[35],"ultimately":[36],"reducing":[37,76],"efficacy":[39],"restricting":[41],"patient":[42],"access.":[43],"Recent":[44],"breakthroughs":[45],"in":[46,60],"biomaterials":[47,105,123],"science,":[48],"immunoengineering,":[49],"genetic":[51],"editing":[52],"catalyzed":[54],"a":[55,130],"paradigm":[56],"shift":[57],"toward":[58],"direct":[59],"immune":[62,112],"engineering":[64],"using":[65],"instructive":[66,104],"biomaterials.":[67],"These":[68],"emerging":[69,142],"strategies":[70],"circumvent":[71],"traditional":[72],"limitations":[73],"dramatically":[75],"eliminating":[78],"delays,":[80],"improving":[82],"therapeutic":[83,147],"outcomes":[84],"through":[85],"preservation":[86],"of":[87,132],"native":[88],"states":[90],"functions.":[92],"Key":[93],"technological":[94],"advances":[95],"include":[96],"highly":[97],"specific":[98],"targeted":[99],"biomaterial-assisted":[100],"gene":[101],"delivery":[102],"that":[106,164],"establish":[107],"controlled":[108],"microenvironments":[109],"precise":[111],"programming":[114],"modulation.":[116],"In":[117],"this":[118],"perspective,":[119],"we":[120,158],"examine":[121],"how":[122],"are":[124],"redefining":[125],"across":[129],"range":[131],"pathological":[133],"contexts,":[134],"from":[135],"cancer":[136],"to":[137,168],"autoimmune":[138],"disease.":[139],"We":[140],"analyze":[141],"breakthrough":[143],"platforms,":[144],"highlight":[145],"potential,":[148],"discuss":[150],"key":[151],"challenges":[152],"limiting":[153],"clinical":[154],"adoption.":[155],"Looking":[156],"ahead,":[157],"provide":[159],"insights":[160],"into":[161],"future":[162],"developments":[163],"could":[165],"democratize":[166],"access":[167],"these":[169],"transformative":[170],"immunotherapies.":[171]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-14T00:00:00"}